JANUMET - 52125-486-60 - (SITAGLIPTIN and METFORMIN HYDROCHLORIDE)

Alphabetical Index


Drug Information of JANUMET

Product NDC: 52125-486
Proprietary Name: JANUMET
Non Proprietary Name: SITAGLIPTIN and METFORMIN HYDROCHLORIDE
Active Ingredient(s): 500; 50    mg/1; mg/1 & nbsp;   SITAGLIPTIN and METFORMIN HYDROCHLORIDE
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of JANUMET

Product NDC: 52125-486
Labeler Name: REMEDYREPACK INC.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022044
Marketing Category: NDA
Start Marketing Date: 20130522

Package Information of JANUMET

Package NDC: 52125-486-60
Package Description: 60 TABLET, FILM COATED in 1 VIAL (52125-486-60)

NDC Information of JANUMET

NDC Code 52125-486-60
Proprietary Name JANUMET
Package Description 60 TABLET, FILM COATED in 1 VIAL (52125-486-60)
Product NDC 52125-486
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name SITAGLIPTIN and METFORMIN HYDROCHLORIDE
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20130522
Marketing Category Name NDA
Labeler Name REMEDYREPACK INC.
Substance Name METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE
Strength Number 500; 50
Strength Unit mg/1; mg/1
Pharmaceutical Classes Biguanide [EPC],Biguanides [Chemical/Ingredient],Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA]

Complete Information of JANUMET


General Information